Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts

NCT01532102 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Anogenital Warts
Condylomata Acuminata
Human Papillomavirus Infection

Interventions

DRUG: AP611074
DRUG: Placebo

Sponsor

Anaconda Pharma